Correlation Between Quoin Pharmaceuticals and Altamira Therapeutics

Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Altamira Therapeutics, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Altamira Therapeutics.

Diversification Opportunities for Quoin Pharmaceuticals and Altamira Therapeutics

-0.02

Correlation Coefficient

Quoin Pharmaceuticals  Altamira Therapeutics

Good diversification

The 3 months correlation between Quoin and Altamira is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Altamira Therapeutics go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Altamira Therapeutics

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Altamira Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Quoin Pharmaceuticals Ltd is 1.44 times less risky than Altamira Therapeutics. The stock trades about -0.41 of its potential returns per unit of risk. The Altamira Therapeutics is currently generating about -0.16 of returns per unit of risk over similar time horizon. If you would invest  48.00  in Altamira Therapeutics on August 31, 2024 and sell it today you would lose (8.00) from holding Altamira Therapeutics or give up 16.67% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Quoin Pharmaceuticals Ltd  vs.  Altamira Therapeutics

Quoin Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Quoin Pharmaceuticals Ltd are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quoin Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Altamira Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Altamira Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Quoin Pharmaceuticals and Altamira Therapeutics

The main advantage of trading using opposite Quoin Pharmaceuticals and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.

The idea behind Quoin Pharmaceuticals Ltd and Altamira Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.